BridgeBio Pharma, Inc.
Public
BBP
SectorHealthcare
CountryUnited States
Market cap14.67B
BridgeBio Pharma, Inc.: A commercial-stage biopharmaceutical company focused on discovering and developing breakthrough medicines for genetic diseases and cancers.
